Postpartum Anticoagulation Guidelines

Primary Recommendations

• The American College of Cardiology recommends low-molecular-weight heparin (LMWH) such as enoxaparin as the preferred anticoagulant for postpartum VTE prophylaxis and treatment with a strong recommendation (Grade 1A) 1, 2, 3, 4
• The standard prophylactic dose of enoxaparin is 40 mg subcutaneously once daily for patients requiring thromboprophylaxis 1, 2, 5
• For postpartum prophylaxis in women with prior VTE, continue LMWH for 6 weeks postpartum 1, 2
• Neither LMWH nor warfarin is secreted in breast milk, making them safe for breastfeeding mothers 1, 2

Specific Clinical Scenarios

• All women undergoing cesarean delivery should receive sequential compression devices starting preoperatively and continuing until fully ambulatory (Grade 1C) 6
• Add pharmacologic prophylaxis with LMWH for 6 weeks postpartum in women with a personal history of DVT or PE (Grade 2C) 6
• LMWH is strongly recommended over unfractionated heparin for acute VTE treatment (strong recommendation, moderate certainty) 3, 4
• Therapeutic dosing of enoxaparin is 1 mg/kg subcutaneously every 12 hours or 1.5 mg/kg once daily 3, 4, 5

Dosing Considerations

• No dose adjustment is needed for enoxaparin in patients with preserved renal function (creatinine clearance >30 mL/min) 5
• Routine anti-factor Xa monitoring is not recommended for most patients on therapeutic LMWH (conditional recommendation) 3, 4

Safety and Efficacy

• LMWH has established safety in breastfeeding with no secretion in breast milk 1, 2
• LMWH offers better bioavailability, longer half-life, more predictable anticoagulation, and lower risk of heparin-induced thrombocytopenia compared to unfractionated heparin 5
• The lack of safety data for DOACs in the postpartum/breastfeeding period makes them inappropriate despite potential convenience advantages 1, 2

Common Pitfalls to Avoid

• Do not use DOACs in the immediate postpartum period or while breastfeeding due to unknown safety profile 1, 2
• Do not fail to adjust timing with neuraxial anesthesia—improper timing increases spinal hematoma risk 5
• Do not assume warfarin is contraindicated in breastfeeding—it is actually safe and can be used as an alternative to LMWH after the first few days postpartum 1, 2
• Do not routinely monitor anti-Xa levels unless in special circumstances (not applicable to standard postpartum prophylaxis) 3, 4